OpenVSafe by OpenVAERS
Search V-safe

BVD-95589-87613

3 vaccinations 9 coded responses 21 check-ins 9 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
191 / PA
Registered
2021-03-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Registered in v-safe
  2. 2021-03-17
    Dose 1 — Moderna
  3. 2021-03-17
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  4. 2021-03-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mobility decreased, Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Very sore arm. Unable raise above chin level
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site rash — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activities
    Free text: Rash on an 2 inches in diameter below injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema, Injection site rash — Feeling: Good · Fatigue or tiredness
    Free text: Red oval rash 2 inches below injection site. 3 inches in diameter.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema, Injection site pruritus — Feeling: Good · Headache, Fatigue or tiredness
    Free text: 2in diameter red oval or ring 2-3 inches below injection site. Itchy as well.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site rash, Rash pruritic — Feeling: Good
    Free text: Itchy rash slowly dissipating 2 inches below injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema, Injection site pruritus — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Itchy red area 2 inches below injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-24
    Survey response — day 7, dose 1
    MedDRA: Rash pruritic — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Mold rash below injection site. 2 inches in diameter. Itchy.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-31
    Survey response — day 14, dose 1
    MedDRA: Injection site pruritus, Injection site rash, Injection site warmth — Feeling: Good
    Free text: Arm rash in circular pattern below injection site still present and larger than prior days. Itchy and hot. Reminiscent of a hot lesion pattern.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-07
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-14
    Dose 2 — Moderna
  14. 2021-04-23
    Health check-in — day 7, dose 2
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  15. 2021-04-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-12-08
    Dose 3 — Moderna
  23. 2022-04-14
    Survey response — 12 months, dose 2
    MedDRA: Headache — Feeling: Good · Be unable to work or attend school
    Free text: Headaches
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-06-08
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-12-10
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Moderna
22021-04-14Moderna
32021-12-08Moderna No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-18

Systemic reaction (other): Very sore arm. Unable raise above chin level

2021-03-19

Systemic reaction (other): Rash on an 2 inches in diameter below injection site

Release 6 — days 1–6 daily, dose 1

2021-03-20

Systemic reaction (other): Red oval rash 2 inches below injection site. 3 inches in diameter.

2021-03-21

Systemic reaction (other): 2in diameter red oval or ring 2-3 inches below injection site. Itchy as well.

2021-03-22

Systemic reaction (other): Itchy rash slowly dissipating 2 inches below injection site

2021-03-23

Systemic reaction (other): Itchy red area 2 inches below injection site

Release 6 — day 7, dose 1

2021-03-24

Systemic reaction (other): Mold rash below injection site. 2 inches in diameter. Itchy.

Release 6 — day 14, dose 1

2021-03-31

Symptoms: Arm rash in circular pattern below injection site still present and larger than prior days. Itchy and hot. Reminiscent of a hot lesion pattern.

Release 11 — 12 months, dose 2

2022-04-14

Symptoms: Headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site rash ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pruritus ✓ ✓ ✓
SROInjection site rash ✓ ✓ ✓
SROMobility decreased ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SRORash pruritic ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release